WIMMER ASSOCIATES 1, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,013 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.

Quarter-by-quarter ownership
WIMMER ASSOCIATES 1, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$326,193
+11.3%
3,064
+1.2%
0.17%
+8.4%
Q1 2024$292,995
-4.2%
3,0290.0%0.15%
-11.0%
Q4 2023$305,838
-6.3%
3,029
-5.5%
0.17%
-15.2%
Q3 2023$326,359
+2.2%
3,204
+1.3%
0.20%
+6.2%
Q2 2023$319,279
+1.1%
3,164
+3.3%
0.19%
-5.0%
Q1 2023$315,960
+56.9%
3,064
+38.0%
0.20%
+51.9%
Q4 2022$201,398
-2.2%
2,220
-5.6%
0.13%
+15.7%
Q1 2022$206,000
-5.5%
2,351
+2.2%
0.12%
-34.3%
Q4 2019$218,000
-41.4%
2,300
-43.6%
0.18%
-46.2%
Q2 2019$372,000
-7.0%
4,076
-2.0%
0.32%
-8.5%
Q1 2019$400,000
+12.0%
4,1610.0%0.36%
+0.3%
Q4 2018$357,000
-0.6%
4,1610.0%0.35%
+18.4%
Q3 2018$359,000
+7.8%
4,161
-5.6%
0.30%
+0.7%
Q2 2018$333,000
-6.7%
4,408
-0.2%
0.30%
-5.7%
Q1 2018$357,000
-3.8%
4,4170.0%0.32%
-5.7%
Q4 2017$371,000
-2.1%
4,4170.0%0.33%
-4.3%
Q3 2017$379,000
-7.6%
4,417
-10.2%
0.35%
-7.7%
Q2 2017$410,000
+12.3%
4,9170.0%0.38%
+10.9%
Q1 2017$365,000
-9.9%
4,917
-11.5%
0.34%
-9.1%
Q4 2016$405,000
+1.5%
5,559
+9.9%
0.38%
+4.5%
Q3 2016$399,000
-9.7%
5,059
-5.6%
0.36%
-8.9%
Q2 2016$442,000
-62.3%
5,359
-66.9%
0.39%
-63.3%
Q1 2016$1,172,000
-18.5%
16,179
-3.2%
1.07%
-28.8%
Q4 2015$1,438,00016,7141.51%
Other shareholders
NOVARTIS A G shareholders Q1 2018
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders